市場調查報告書
商品編碼
1287391
血液透析市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Hemodialysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球血液透析市場規模達到870億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到1114億美元,在2023-2028年期間呈現3.8%的成長率(CAGR)。
血液透析是指當腎臟功能低於10%-15%時進行的醫療程序。在這個過程中,透析器或人工腎臟用來過濾血液中多餘的液體和毒素,並恢復電解質平衡。它從血液中清除廢物,如肌酐和尿素,並改善腎臟的功能。它還有助於管理血壓水平,平衡循環系統中鈉、鉀和鈣等礦物質的濃度。此外,該程序還能防止鹽分和其他毒素的積累,這些毒素會損害和影響身體其他器官的功能。
全球範圍內各種疾病,如末期腎臟病(ESRD)和慢性腎臟病(CKD)的日益流行,是推動市場成長的關鍵因素之一。這些疾病通常是由高血壓、高血脂、糖尿病、過度酗酒和濫用藥物引起的。在這種情況下,腎臟功能也會逐漸喪失,造成健康狀況下降和神經損傷。血液透析有助於穩定血壓水平和恢復營養健康。此外,消費者對及時診斷和治療腎臟疾病的好處的認識不斷提高,增加了對血液透析設備的採用。此外,各種技術創新,包括推出可以方便地用於家庭治療的緊湊尺寸的機器,都大大促進了產品需求。其他因素,如加強研究和開發(R&D),促進公共醫療基礎設施的有利的政府政策,以及治療過程中自動化的上升趨勢,預計將進一步推動市場。
The global hemodialysis market size reached US$ 87.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 111.4 Billion by 2028, exhibiting a growth rate (CAGR) of 3.8% during 2023-2028.
Hemodialysis refers to the medical procedure that is performed when the kidney function goes below 10%-15%. In this procedure, a dialyzer, or artificial kidney, is used to filter excess fluids and toxins from the blood and restore the electrolyte balance. It removes waste products such as creatinine and urea from the blood and improves the functioning of the kidneys. It also aids in managing blood pressure levels and balances the concentration of minerals such as sodium, potassium and calcium in the circulatory system. Furthermore, the procedure prevents the accumulation of salts and other toxins that can damage and influence the functioning of other organs in the body.
The growing prevalence of various diseases, such as End-Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD), across the globe, is one of the key factors driving the growth of the market. These diseases are usually caused by high blood pressure, hypertension, diabetes, excessive alcoholism and drug abuse. There is also a gradual loss of kidney functioning in such cases, which leads to declining health and nerve damage. Hemodialysis assists in stabilizing blood pressure levels and restoring nutritional health. Furthermore, rising consumer awareness regarding the benefits of timely diagnosis and treatment of kidney disorders has increased the adoption of hemodialysis devices. Additionally, various technological innovations, including the introduction of compact-sized machines that can be conveniently used for home-based treatments, are significantly boosting the product demand. Other factors such as enhanced research and development (R&D), favorable government policies to promote public healthcare infrastructure, and the rising trend of automation in treatment processes are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global hemodialysis market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on segment, modality and end-user.
The report has also analyzed the competitive landscape of the market with some of the key players being Baxter International, Asahi Kasei Corporation, B. Barun Melsungen, DaVita, Cantel Medical Corporation, Fresenius Medical Care, Nipro Corporation, Rockwell Medical, Medivators, Toray Medical Company Ltd., Nikkiso Co. Ltd., Surni Group, Gambro, Satellite Healthcare Inc. and Renacon Pharma Ltd., etc.